Unknown

Dataset Information

0

Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation.


ABSTRACT: It is not known whether patients with atrial fibrillation (AF) with ischemic stroke despite oral anticoagulant therapy are at increased risk for further recurrent strokes or how ongoing secondary prevention should be managed. We conducted an individual patient data pooled analysis of 7 prospective cohort studies that recruited patients with AF and recent cerebral ischemia. We compared patients taking oral anticoagulants (vitamin K antagonists [VKA] or direct oral anticoagulants [DOAC]) prior to index event (OACprior ) with those without prior oral anticoagulation (OACnaive ). We further compared those who changed the type (ie, from VKA or DOAC, vice versa, or DOAC to DOAC) of anticoagulation (OACchanged ) with those who continued the same anticoagulation as secondary prevention (OACunchanged ). Time to recurrent acute ischemic stroke (AIS) was analyzed using multivariate competing risk Fine-Gray models to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). We included 5,413 patients (median age = 78 years [interquartile range (IQR) = 71-84 years]; 5,136 [96.7%] had ischemic stroke as the index event, median National Institutes of Health Stroke Scale on admission = 6 [IQR = 2-12]). The median CHA2 DS2 -Vasc score (congestive heart failure, hypertension, age≥ 75 years, diabetes mellitus, stroke/transient ischemic attack, vascular disease, age 65-74 years, sex category) was 5 (IQR = 4-6) and was similar for OACprior (n = 1,195) and OACnaive (n = 4,119, p = 0.103). During 6,128 patient-years of follow-up, 289 patients had AIS (4.7% per year, 95% CI = 4.2-5.3%). OACprior was associated with an increased risk of AIS (HR = 1.6, 95% CI = 1.2-2.3, p = 0.005). OACchanged (n = 307) was not associated with decreased risk of AIS (HR = 1.2, 95% CI = 0.7-2.1, p = 0.415) compared with OACunchanged (n = 585). Patients with AF who have an ischemic stroke despite previous oral anticoagulation are at a higher risk for recurrent ischemic stroke despite a CHA2 DS2 -Vasc score similar to those without prior oral anticoagulation. Better prevention strategies are needed for this high-risk patient group. ANN NEUROL 2020.

SUBMITTER: Seiffge DJ 

PROVIDER: S-EPMC7383617 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation.

Seiffge David J DJ   De Marchis Gian Marco GM   Koga Masatoshi M   Paciaroni Maurizio M   Wilson Duncan D   Cappellari Manuel M   Macha Md Kosmas K   Tsivgoulis Georgios G   Ambler Gareth G   Arihiro Shoji S   Bonati Leo H LH   Bonetti Bruno B   Kallmünzer Bernd B   Muir Keith W KW   Bovi Paolo P   Gensicke Henrik H   Inoue Manabu M   Schwab Stefan S   Yaghi Shadi S   Brown Martin M MM   Lyrer Philippe P   Takagi Masahito M   Acciarrese Monica M   Jager Hans Rolf HR   Polymeris Alexandros A AA   Toyoda Kazunori K   Venti Michele M   Traenka Christopher C   Yamagami Hiroshi H   Alberti Andrea A   Yoshimura Sohei S   Caso Valeria V   Engelter Stefan T ST   Werring David J DJ  

Annals of neurology 20200212


<h4>Objective</h4>It is not known whether patients with atrial fibrillation (AF) with ischemic stroke despite oral anticoagulant therapy are at increased risk for further recurrent strokes or how ongoing secondary prevention should be managed.<h4>Methods</h4>We conducted an individual patient data pooled analysis of 7 prospective cohort studies that recruited patients with AF and recent cerebral ischemia. We compared patients taking oral anticoagulants (vitamin K antagonists [VKA] or direct oral  ...[more]

Similar Datasets

| S-EPMC10502439 | biostudies-literature
| S-EPMC10532406 | biostudies-literature
| S-EPMC9005870 | biostudies-literature
| S-EPMC4512906 | biostudies-literature
| S-EPMC10644758 | biostudies-literature
| S-EPMC9354040 | biostudies-literature
| S-EPMC9795305 | biostudies-literature
| S-EPMC3968084 | biostudies-other
| S-EPMC8322995 | biostudies-literature
| S-EPMC5712199 | biostudies-literature